Paid Clinical Trials and Focus Groups by Category |
|
|
|
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: INSULIN GLARGINE; Drug: INSULIN GLULISINE
Sponsor: Sanofi-Aventis
Recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: NN1250; Drug: insulin glargine; Drug: NN1250; Drug: insulin aspart
Sponsor: Novo Nordisk
Recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Insulin glulisine; Drug: Insulin glargine; Drug: Premixed insulin (Insulin Aspart 30/70 )
Sponsor: Sanofi-Aventis
Recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: NN1250; Drug: insulin glargine
Sponsor: Novo Nordisk
Recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Insulin Glargine; Drug: LY2189265
Sponsor: Eli Lilly and Company
Not yet recruiting - verified February 2010